M K Proteins Ltd

  • BSE Code : 543919
  • NSE Symbol : MKPL
  • ISIN : INE964W01021
  • Industry :SOLVENT EXTRACTION

up-arrow 7.71 0.28(3.77%)

Open Price ()

7.40

Prev. Close ()

7.43

Volume (No’s)

452,433

Market Cap ()

289.41

Low Price ()

7.05

High Price ()

7.80

 

Book Closure

From Date To Date Announcement
23-May-2025 NA M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 inter alia to consider and approve 1. The Audited Financial Results of the Company for the quarter and year ended 31st March 2025; 2. Re-Appointment of M/s. K. K. Sinha & Associates Cost Accountants (Firm Regn. No. 100279) as the Cost Auditors of the Company for the financial year 2025-2026. 3. Any other items with the permission of the chairman. We hereby inform that the Board of Directors of the Company at its meeting held today i.e. on Friday, May 23, 2025, inter alia, considered and approved the following matters: 1. Audited Standalone Financial Results of the Company for the Quarter and Year ended on 31st March, 2025 together with a Statement of Cash Flow, Statement of Assets and Liabilities for the same period; 2. Auditors Report on the said Financial Results; 3. Declaration regarding unmodified opinion on Audited Standalone Financial Results under Regulation 33(3)(d) of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2016 (As Per BSE Announcement Dated on: 23/05/2025)
13-Feb-2025 NA M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 inter alia to consider and approve the following items: 1. The Un-Audited Financial Results of the Company for the quarter and nine months ended 31st December 2024; 2. Any other business with the permission of chair. Pursuant to the Regulations 30 and 33 of SEBI (LODR) Regulations, 2015, we hereby inform that the Board of Directors of the Company at its meeting held today i.e. on Thursday, February 13, 2025, inter alia, considered and approved the Un-Audited Financial Results for the quarter and nine months ended December 31, 2024 along with the Limited Review Report thereon by the Statutory Auditors of the Company. A copy of the Un-Audited Financial Results along with Limited Review Report of the Auditors is attached herewith as Annexures. The meeting of the Board of Directors commenced at 05:00 P.M. and concluded at 05:40 P.M. (As Per BSE Announcement Dated on 13.02.2025)
14-Nov-2024 NA M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve the following businesses: 1. The Un-audited Financial Results of the Company for the quarter and half year ended 30th September 2024; 2. Any other items with the permission of the chairman. Further pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for prevention of Insider Trading (Code) the Trading Window for trading in Equity shares of the Company will be accordingly re-open after 48 hours from the declaration of the aforesaid Financial Results. Pursuant to the Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of the Company at its meeting held today i.e. on Thursday, November 14, 2024, inter alia, considered and approved the Un-Audited Financial Results for the quarter and half year ended September 30, 2024 along with the Limited Review Report thereon by the Statutory Auditors of the Company. A copy of the Un-Audited Financial Results along with Limited Review Report of the Auditors is attached herewith as Annexures. Please note that the meeting of the Board of Directors commenced at 04:00 p.m. and concluded at 4:30 p.m. You are requested to take the same on your record. (As Per BSE Announcement dated on 14.11.2024)
04-Oct-2024 NA Neelesh Garg
04-Oct-2024 NA Manik Garg

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew